Compare IDYA & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | ALGT |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 2.9B |
| IPO Year | 2019 | 2006 |
| Metric | IDYA | ALGT |
|---|---|---|
| Price | $39.98 | $72.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 10 |
| Target Price | $52.86 | ★ $97.30 |
| AVG Volume (30 Days) | ★ 701.7K | 521.6K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.90 | ★ 81.62 |
| EPS | N/A | ★ 1.80 |
| Revenue | $218,710,000.00 | ★ $2,606,579,000.00 |
| Revenue This Year | N/A | $9.42 |
| Revenue Next Year | $201.05 | $6.52 |
| P/E Ratio | ★ N/A | $42.25 |
| Revenue Growth | ★ 3024.43 | 3.74 |
| 52 Week Low | $23.23 | $57.11 |
| 52 Week High | $42.68 | $123.63 |
| Indicator | IDYA | ALGT |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 28.57 |
| Support Level | $33.57 | $69.96 |
| Resistance Level | $39.93 | $94.59 |
| Average True Range (ATR) | 1.35 | 3.30 |
| MACD | 0.09 | -0.49 |
| Stochastic Oscillator | 59.26 | 0.00 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.